Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [1] Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia
    Yilmaz, BT
    Alioglu, B
    Ozyurek, E
    Akay, HT
    Mercan, S
    Ozbek, N
    PEDIATRIC CARDIOLOGY, 2005, 26 (06) : 843 - 845
  • [2] Successful use of recombinant factor VIIa (NovoSeven®) during cardiac surgery in a pediatric patient with congenital factor XI deficiency
    Avci, Zekai
    Malbora, Baris
    Gokdemir, Mahmut
    Ozkan, Suleyman
    Ozbek, Namik
    PEDIATRIC CARDIOLOGY, 2008, 29 (01) : 220 - 222
  • [3] Successful Use of Recombinant Factor VIIa (NovoSeven®) During Cardiac Surgery in a Pediatric Patient with Congenital Factor XI Deficiency
    Zekai Avci
    Baris Malbora
    Mahmut Gokdemir
    Suleyman Ozkan
    Namik Ozbek
    Pediatric Cardiology, 2008, 29 : 220 - 222
  • [4] Use of recombinant factor viia for bleeding in children with Glanzmann thrombasthenia
    Çaglar, K
    Çetinkaya, A
    Aytaç, S
    Gümrük, F
    Gürgey, A
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20 (06) : 435 - 438
  • [5] Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia
    van Buuren, HR
    Wielenga, JJ
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (09) : 2134 - 2136
  • [6] Recombinant Factor VIIa in Pediatric Cardiac Surgery
    Morrison, Shannon
    Lacey, Cara
    Attard, Chantal
    Davies, Ben
    Monagle, Paul
    Davies, Paul
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (03) : 684 - 689
  • [7] CASE REPORT: Successful Surgery Using Recombinant Factor VIIa for Recurrent, Idiopathic Nonulcer Duodenal Bleeding in a Patient with Glanzmann's Thrombasthenia
    Henk R. van Buuren
    Jenne J. Wielenga
    Digestive Diseases and Sciences, 2002, 47 : 2134 - 2136
  • [8] Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report
    Enciso, Leonardo
    Aragon-Mendoza, Rafael L.
    Leon, Laura A.
    Torres-Torres, Carrie G.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [9] Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a
    Hennewig, U
    Laws, HJ
    Eisert, S
    Göbel, U
    KLINISCHE PADIATRIE, 2005, 217 (06): : 365 - 370
  • [10] Adjunct use of NovoSeven (recombinant factor VIIa) for penetrating cardiac trauma
    Manuel Garcia-Nunez, Luis
    Enrique Soto-Ortega, Luis
    Cabello-Pasini, Ruy
    Enrique Payro-Hernandez, Luis
    Javier Magana-Sanchez, Ignacio
    CIRUGIA Y CIRUJANOS, 2008, 76 (01): : 95 - 98
12345